Cargando…

Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression

SIMPLE SUMMARY: Epithelial–mesenchymal transition (EMT) is associated with cancer progression. Here, we found that two secreted proteins of osteomodulin (OMD) and proline/arginine-rich end leucine repeat protein (PRELP) were selectively expressed in bladder umbrella epithelial cells, and they were s...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadaki, Vasiliki, Asada, Ken, Watson, Julie K., Tamura, Toshiya, Leung, Alex, Hopkins, Jack, Dellett, Margaret, Sasai, Noriaki, Davaapil, Hongorzul, Nik-Zainal, Serena, Longbottom, Rebecca, Nakakido, Makoto, Torii, Ryo, Veerakumarasivam, Abhi, Kaneko, Syuzo, Sagoo, Mandeep S., Murphy, Gillian, Mitani, Akihisa, Tsumoto, Kohei, Kelly, John D., Hamamoto, Ryuji, Ohnuma, Shin-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697838/
https://www.ncbi.nlm.nih.gov/pubmed/33202923
http://dx.doi.org/10.3390/cancers12113362
_version_ 1783615690504142848
author Papadaki, Vasiliki
Asada, Ken
Watson, Julie K.
Tamura, Toshiya
Leung, Alex
Hopkins, Jack
Dellett, Margaret
Sasai, Noriaki
Davaapil, Hongorzul
Nik-Zainal, Serena
Longbottom, Rebecca
Nakakido, Makoto
Torii, Ryo
Veerakumarasivam, Abhi
Kaneko, Syuzo
Sagoo, Mandeep S.
Murphy, Gillian
Mitani, Akihisa
Tsumoto, Kohei
Kelly, John D.
Hamamoto, Ryuji
Ohnuma, Shin-ichi
author_facet Papadaki, Vasiliki
Asada, Ken
Watson, Julie K.
Tamura, Toshiya
Leung, Alex
Hopkins, Jack
Dellett, Margaret
Sasai, Noriaki
Davaapil, Hongorzul
Nik-Zainal, Serena
Longbottom, Rebecca
Nakakido, Makoto
Torii, Ryo
Veerakumarasivam, Abhi
Kaneko, Syuzo
Sagoo, Mandeep S.
Murphy, Gillian
Mitani, Akihisa
Tsumoto, Kohei
Kelly, John D.
Hamamoto, Ryuji
Ohnuma, Shin-ichi
author_sort Papadaki, Vasiliki
collection PubMed
description SIMPLE SUMMARY: Epithelial–mesenchymal transition (EMT) is associated with cancer progression. Here, we found that two secreted proteins of osteomodulin (OMD) and proline/arginine-rich end leucine repeat protein (PRELP) were selectively expressed in bladder umbrella epithelial cells, and they were suppressed in bladder cancer. We revealed that OMD(−/−) or PRELP(−/−) knockout mice caused a breakdown of the umbrella cell layer through weakening cell–cell integrity and the activation of partial EMT, which resulted in the formation of early bladder cancer-like structures, while OMD or PRELP application to bladder cancer cells inhibited cancer progression through reversing EMT, which was mediated by the inhibition of TGF-β and EGF. Our result indicates that OMD and PRELP function as tumor-suppressing proteins through inhibiting EMT. OMD and PRELP may be potential therapeutic targets in bladder cancer. ABSTRACT: Osteomodulin (OMD) and proline/arginine-rich end leucine repeat protein (PRELP) are secreted extracellular matrix proteins belonging to the small leucine-rich proteoglycans family. We found that OMD and PRELP were specifically expressed in umbrella cells in bladder epithelia, and their expression levels were dramatically downregulated in all bladder cancers from very early stages and various epithelial cancers. Our in vitro studies including gene expression profiling using bladder cancer cell lines revealed that OMD or PRELP application suppressed the cancer progression by inhibiting TGF-β and EGF pathways, which reversed epithelial–mesenchymal transition (EMT), activated cell–cell adhesion, and inhibited various oncogenic pathways. Furthermore, the overexpression of OMD in bladder cancer cells strongly inhibited the anchorage-independent growth and tumorigenicity in mouse xenograft studies. On the other hand, we found that in the bladder epithelia, the knockout mice of OMD and/or PRELP gene caused partial EMT and a loss of tight junctions of the umbrella cells and resulted in formation of a bladder carcinoma in situ-like structure by spontaneous breakdowns of the umbrella cell layer. Furthermore, the ontological analysis of the expression profiling of an OMD knockout mouse bladder demonstrated very high similarity with those obtained from human bladder cancers. Our data indicate that OMD and PRELP are endogenous inhibitors of cancer initiation and progression by controlling EMT. OMD and/or PRELP may have potential for the treatment of bladder cancer.
format Online
Article
Text
id pubmed-7697838
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76978382020-11-29 Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression Papadaki, Vasiliki Asada, Ken Watson, Julie K. Tamura, Toshiya Leung, Alex Hopkins, Jack Dellett, Margaret Sasai, Noriaki Davaapil, Hongorzul Nik-Zainal, Serena Longbottom, Rebecca Nakakido, Makoto Torii, Ryo Veerakumarasivam, Abhi Kaneko, Syuzo Sagoo, Mandeep S. Murphy, Gillian Mitani, Akihisa Tsumoto, Kohei Kelly, John D. Hamamoto, Ryuji Ohnuma, Shin-ichi Cancers (Basel) Article SIMPLE SUMMARY: Epithelial–mesenchymal transition (EMT) is associated with cancer progression. Here, we found that two secreted proteins of osteomodulin (OMD) and proline/arginine-rich end leucine repeat protein (PRELP) were selectively expressed in bladder umbrella epithelial cells, and they were suppressed in bladder cancer. We revealed that OMD(−/−) or PRELP(−/−) knockout mice caused a breakdown of the umbrella cell layer through weakening cell–cell integrity and the activation of partial EMT, which resulted in the formation of early bladder cancer-like structures, while OMD or PRELP application to bladder cancer cells inhibited cancer progression through reversing EMT, which was mediated by the inhibition of TGF-β and EGF. Our result indicates that OMD and PRELP function as tumor-suppressing proteins through inhibiting EMT. OMD and PRELP may be potential therapeutic targets in bladder cancer. ABSTRACT: Osteomodulin (OMD) and proline/arginine-rich end leucine repeat protein (PRELP) are secreted extracellular matrix proteins belonging to the small leucine-rich proteoglycans family. We found that OMD and PRELP were specifically expressed in umbrella cells in bladder epithelia, and their expression levels were dramatically downregulated in all bladder cancers from very early stages and various epithelial cancers. Our in vitro studies including gene expression profiling using bladder cancer cell lines revealed that OMD or PRELP application suppressed the cancer progression by inhibiting TGF-β and EGF pathways, which reversed epithelial–mesenchymal transition (EMT), activated cell–cell adhesion, and inhibited various oncogenic pathways. Furthermore, the overexpression of OMD in bladder cancer cells strongly inhibited the anchorage-independent growth and tumorigenicity in mouse xenograft studies. On the other hand, we found that in the bladder epithelia, the knockout mice of OMD and/or PRELP gene caused partial EMT and a loss of tight junctions of the umbrella cells and resulted in formation of a bladder carcinoma in situ-like structure by spontaneous breakdowns of the umbrella cell layer. Furthermore, the ontological analysis of the expression profiling of an OMD knockout mouse bladder demonstrated very high similarity with those obtained from human bladder cancers. Our data indicate that OMD and PRELP are endogenous inhibitors of cancer initiation and progression by controlling EMT. OMD and/or PRELP may have potential for the treatment of bladder cancer. MDPI 2020-11-13 /pmc/articles/PMC7697838/ /pubmed/33202923 http://dx.doi.org/10.3390/cancers12113362 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Papadaki, Vasiliki
Asada, Ken
Watson, Julie K.
Tamura, Toshiya
Leung, Alex
Hopkins, Jack
Dellett, Margaret
Sasai, Noriaki
Davaapil, Hongorzul
Nik-Zainal, Serena
Longbottom, Rebecca
Nakakido, Makoto
Torii, Ryo
Veerakumarasivam, Abhi
Kaneko, Syuzo
Sagoo, Mandeep S.
Murphy, Gillian
Mitani, Akihisa
Tsumoto, Kohei
Kelly, John D.
Hamamoto, Ryuji
Ohnuma, Shin-ichi
Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression
title Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression
title_full Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression
title_fullStr Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression
title_full_unstemmed Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression
title_short Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression
title_sort two secreted proteoglycans, activators of urothelial cell–cell adhesion, negatively contribute to bladder cancer initiation and progression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697838/
https://www.ncbi.nlm.nih.gov/pubmed/33202923
http://dx.doi.org/10.3390/cancers12113362
work_keys_str_mv AT papadakivasiliki twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT asadaken twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT watsonjuliek twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT tamuratoshiya twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT leungalex twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT hopkinsjack twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT dellettmargaret twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT sasainoriaki twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT davaapilhongorzul twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT nikzainalserena twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT longbottomrebecca twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT nakakidomakoto twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT toriiryo twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT veerakumarasivamabhi twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT kanekosyuzo twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT sagoomandeeps twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT murphygillian twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT mitaniakihisa twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT tsumotokohei twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT kellyjohnd twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT hamamotoryuji twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression
AT ohnumashinichi twosecretedproteoglycansactivatorsofurothelialcellcelladhesionnegativelycontributetobladdercancerinitiationandprogression